The Virtual Myeloma Community Workshop will focus on topics concerning relapsed/refractory myeloma patients. This second installment in a three-part series focuses on myeloma treatment options at time of relapse. Learn more about treatment response, disease progression and management approaches at time of relapse. We will review treatment strategies, the importance of clinical trials, symptom management, and being a part of treatment decision making to help you live your best life with myeloma. After each presentation with the experts, attendees will have ample time to ask questions. 

Welcome and Announcements 

Robin Tuohy
Workshop Moderator
IMF Senior Vice President, Patient Support 

Myeloma 202: Response, Progression, and What It All Means

Joseph Mikhael, MD, Med, FRCPC, FACP, FASCO
IMF Chief Medical Officer
(TGen, City of Hope—Phoenix, AZ)  

The Treatment Landscape for Relapsed Myeloma

Brea Lipe, MD
Professor of Medicine
Clinical Director, Myeloma Program at James P. Wilmot Cancer Center
(University of Rochester Medical Center—Rochester, NY) 

CAR-T: You’re in the Driver’s Seat

Yi Lin, MD, PhD
Hematologist/Oncologist
Professor of Medicine
(Mayo Clinic—Rochester, MN)

Living Your Best Myeloma Life: Side Effect Management and Patient Empowerment

Rebecca Lu, MSN, FNP-C
IMF Nurse Leadership Board Member
(MD Anderson Cancer Center—Houston, TX) 

Faculty Roundtable: Demystifying Clinical Trials 

Panel Q&A 

Workshop Sponsors:

With Support From: Abbvie, Amgen, GSK, Johnson & Johnson, Karyopharm, Pfizer, Sanofi, and Takeda Oncology

(The IMF is not responsible for content provided by the links below and you may be subject to the Privacy Policy and Terms & Conditions of the destination site(s).)

	Cervino Study CLINICAL TRIAL FACT SHEET ClinicalTrials.gov ID: NCT06158841 HOJA INFORMATIVA DEL ENSAYO CLÍNICO ID de ClinicalTrials.gov: NCT06158841
	Darzalex® Talvey Tecvayli: Digital Patient Brochure
	KaryForward, Patient Support Program KaryForward, Patient Support Program, Espanol Patient and Caregiver Brochure Treatment Experience Guide
	ELREXFIO® (elranatamab-bcmm) Info for Patients | Safety Info Your Guide to Understanding Elrexfio ELREXFIO® (elranatamab-bcmm) Personalized Patient Support | Safety Info
	SARCLISA® (isatuximab-irfc) | A Targeted Immunotherapy CareASSIST - Patient Assistance Program for SARCLISA® (isatuximab-irfc) A Study to Investigate Subcutaneous Isatuximab in Combination | Clinical Research Studies Listing
	Multiple Myeloma Relapse Guide - NINLARO® (ixazomib) Understanding your Multiple Myeloma Lab Tests (ninlaro.com) Working with Your Care Team (ninlaro.com)